Projects

As innovator for antiviral and antibacterial therapies, AiCuris targets infectious diseases with high unmet medical need today, while also preparing for future threats. With the experience of big pharma but the flexibility and scalability of a small biotech, we are driven by scientific expertise and collaborate with a wide array of academic and business partners. This enables us access to various technologies, platforms and sub-contractors – each time selected according to project needs.

Solving the medical needs of today

Prevymis® / Letermovir (AIC246)
Prevymis® / Letermovir (AIC246)

A paradigm shift in HCMV prophylaxis

Read more
Pritelivir (AIC316)
Pritelivir (AIC316)

Treating acyclovir-resistant HSV infection

Read more
AIC649 and HBV research approaches
AIC649 and HBV research approaches

Achieving cure from HBV infection

Read more
AdV research approaches
AdV research approaches

Adenovirus-specific treatment for ocular infections

Read more
Artilysins®
Artilysins®

Treating life-threatening bacterial blood-stream infections

Read more

Preparing for future threats

AIC649 and IMI CARE approaches
AIC649 and IMI CARE approaches

Combatting pandemic viruses such as SARS-CoV-2

Read more
AMR research approaches
AMR research approaches

Combatting rising Anti-microbial resistance (AMR)

Read more

If you or your company are interested in partnering with AiCuris, please contact us.

Contact